APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ambrisentan Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Ambrisentan Drug Market Analysis and Forecast 2026-2032

20 December 2025198 pages

Choose your research edition.

Industry ResearchAmbrisentan Drug Industry Research Report 2026104 pages · $2,950 USDIndustry Growth & TrendsGlobal Ambrisentan Drug Industry Growth and Trends Forecast to 203261 pages · $3,450 USDMarket StructureGlobal Ambrisentan Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032173 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ambrisentan Drug Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Ambrisentan Drug Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Ambrisentan Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Ambrisentan Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Ambrisentan Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Ambrisentan Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Ambrisentan Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Ambrisentan Drug include Gilead Sciences, Hansoh Pharma and GSK, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Ambrisentan Drug, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Ambrisentan Drug, also provides the revenue of main regions and countries. Of the upcoming market potential for Ambrisentan Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Ambrisentan Drug revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Ambrisentan Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Ambrisentan Drug revenue, projected growth trends, production technology, application and end-user industry.

Ambrisentan Drug Segment by Company

Gilead Sciences

Hansoh Pharma

GSK

Ambrisentan Drug Segment by Type

5 mg Tablet

10 mg Tablet

Ambrisentan Drug Segment by Application

Hospital

Drug store

Ambrisentan Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ambrisentan Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ambrisentan Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ambrisentan Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Ambrisentan Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Ambrisentan Drug company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Ambrisentan Drug revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Ambrisentan Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 5 mg Tablet Major Player Table 3. 10 mg Tablet Major Player Table 4. Global Ambrisentan Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Player Table 6. Drug store Major Player Table 7. Ambrisentan Drug Industry Trends Table 8. Ambrisentan Drug Industry Drivers Table 9. Ambrisentan Drug Industry Opportunities and Challenges Table 10. Ambrisentan Drug Industry Restraints Table 11. Global Ambrisentan Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Ambrisentan Drug Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Ambrisentan Drug Market Share by Region (2021-2026) Table 14. Global Ambrisentan Drug Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Ambrisentan Drug Market Share by Region (2027-2032) Table 16. Global Ambrisentan Drug Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Ambrisentan Drug Revenue Market Share by Players (2021-2026) Table 18. Global Ambrisentan Drug Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Ambrisentan Drug Key Players Headquarters & Area Served Table 20. Global Ambrisentan Drug Players, Product Type & Application Table 21. Global Ambrisentan Drug Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Ambrisentan Drug by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Ambrisentan Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Ambrisentan Drug Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Ambrisentan Drug Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Ambrisentan Drug Revenue Market Share by Type (2021-2026) Table 28. Global Ambrisentan Drug Revenue Market Share by Type (2027-2032) Table 29. Global Ambrisentan Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Ambrisentan Drug Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Ambrisentan Drug Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Ambrisentan Drug Revenue Market Share by Application (2021-2026) Table 33. Global Ambrisentan Drug Revenue Market Share by Application (2027-2032) Table 34. Gilead Sciences Company Information Table 35. Gilead Sciences Business Overview Table 36. Gilead Sciences Ambrisentan Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Gilead Sciences Ambrisentan Drug Product Portfolio Table 38. Gilead Sciences Recent Development Table 39. Hansoh Pharma Company Information Table 40. Hansoh Pharma Business Overview Table 41. Hansoh Pharma Ambrisentan Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Hansoh Pharma Ambrisentan Drug Product Portfolio Table 43. Hansoh Pharma Recent Development Table 44. GSK Company Information Table 45. GSK Business Overview Table 46. GSK Ambrisentan Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. GSK Ambrisentan Drug Product Portfolio Table 48. GSK Recent Development Table 49. North America Ambrisentan Drug Revenue by Type (2021-2026) & (US$ Million) Table 50. North America Ambrisentan Drug Revenue by Type (2027-2032) & (US$ Million) Table 51. North America Ambrisentan Drug Revenue by Application (2021-2026) & (US$ Million) Table 52. North America Ambrisentan Drug Revenue by Application (2027-2032) & (US$ Million) Table 53. North America Ambrisentan Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 54. North America Ambrisentan Drug Revenue by Country (2021-2026) & (US$ Million) Table 55. North America Ambrisentan Drug Revenue by Country (US$ Million) & (2027-2032) Table 56. Europe Ambrisentan Drug Revenue by Type (2021-2026) & (US$ Million) Table 57. Europe Ambrisentan Drug Revenue by Type (2027-2032) & (US$ Million) Table 58. Europe Ambrisentan Drug Revenue by Application (2021-2026) & (US$ Million) Table 59. Europe Ambrisentan Drug Revenue by Application (2027-2032) & (US$ Million) Table 60. Europe Ambrisentan Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 61. Europe Ambrisentan Drug Revenue by Country (2021-2026) & (US$ Million) Table 62. Europe Ambrisentan Drug Revenue by Country (US$ Million) & (2027-2032) Table 63. China Ambrisentan Drug Revenue by Type (2021-2026) & (US$ Million) Table 64. China Ambrisentan Drug Revenue by Type (2027-2032) & (US$ Million) Table 65. China Ambrisentan Drug Revenue by Application (2021-2026) & (US$ Million) Table 66. China Ambrisentan Drug Revenue by Application (2027-2032) & (US$ Million) Table 67. Asia Ambrisentan Drug Revenue by Type (2021-2026) & (US$ Million) Table 68. Asia Ambrisentan Drug Revenue by Type (2027-2032) & (US$ Million) Table 69. Asia Ambrisentan Drug Revenue by Application (2021-2026) & (US$ Million) Table 70. Asia Ambrisentan Drug Revenue by Application (2027-2032) & (US$ Million) Table 71. Asia Ambrisentan Drug Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 72. Asia Ambrisentan Drug Revenue by Region (US$ Million) & (2021-2026) Table 73. Asia Ambrisentan Drug Revenue by Region (US$ Million) & (2027-2032) Table 74. SAMEA Ambrisentan Drug Revenue by Type (2021-2026) & (US$ Million) Table 75. SAMEA Ambrisentan Drug Revenue by Type (2027-2032) & (US$ Million) Table 76. SAMEA Ambrisentan Drug Revenue by Application (2021-2026) & (US$ Million) Table 77. SAMEA Ambrisentan Drug Revenue by Application (2027-2032) & (US$ Million) Table 78. SAMEA Ambrisentan Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 79. SAMEA Ambrisentan Drug Revenue by Country (2021-2026) & (US$ Million) Table 80. SAMEA Ambrisentan Drug Revenue by Country (US$ Million) & (2027-2032) Table 81. Research Programs/Design for This Report Table 82. Authors List of This Report Table 83. Secondary Sources Table 84. Primary Sources List of Figures Figure 1. Ambrisentan Drug Image Figure 2. Global Ambrisentan Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ambrisentan Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. 5 mg Tablet Image Figure 5. 10 mg Tablet Image Figure 6. Global Ambrisentan Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Ambrisentan Drug Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Drug store Image Figure 10. Global Ambrisentan Drug Market Size (US$ Million) & (2021-2032) Figure 11. Global Ambrisentan Drug Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Ambrisentan Drug Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Ambrisentan Drug Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Ambrisentan Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Ambrisentan Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Ambrisentan Drug Revenue Market Share by Type (2021-2032) Figure 18. Global Ambrisentan Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Ambrisentan Drug Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Ambrisentan Drug Revenue Market Share by Application (2021-2032) Figure 21. North America Ambrisentan Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Ambrisentan Drug Revenue Share by Type (2021-2032) Figure 23. North America Ambrisentan Drug Revenue Share by Application (2021-2032) Figure 24. North America Ambrisentan Drug Revenue Share by Country (2021-2032) Figure 25. United States Ambrisentan Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Ambrisentan Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Ambrisentan Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Ambrisentan Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Ambrisentan Drug Revenue Share by Type (2021-2032) Figure 30. Europe Ambrisentan Drug Revenue Share by Application (2021-2032) Figure 31. Europe Ambrisentan Drug Revenue Share by Country (2021-2032) Figure 32. Germany Ambrisentan Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Ambrisentan Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Ambrisentan Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Ambrisentan Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Ambrisentan Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Ambrisentan Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Ambrisentan Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Ambrisentan Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Ambrisentan Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Ambrisentan Drug Revenue Share by Type (2021-2032) Figure 42. China Ambrisentan Drug Revenue Share by Application (2021-2032) Figure 43. Asia Ambrisentan Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Ambrisentan Drug Revenue Share by Type (2021-2032) Figure 45. Asia Ambrisentan Drug Revenue Share by Application (2021-2032) Figure 46. Asia Ambrisentan Drug Revenue Share by Region (2021-2032) Figure 47. Japan Ambrisentan Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Ambrisentan Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Ambrisentan Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Ambrisentan Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Ambrisentan Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Ambrisentan Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Ambrisentan Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Ambrisentan Drug Revenue Share by Type (2021-2032) Figure 55. SAMEA Ambrisentan Drug Revenue Share by Application (2021-2032) Figure 56. SAMEA Ambrisentan Drug Revenue Share by Country (2021-2032) Figure 57. Brazil Ambrisentan Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Ambrisentan Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Ambrisentan Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Ambrisentan Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Ambrisentan Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Ambrisentan Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Ambrisentan Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Ambrisentan Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Ambrisentan Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Ambrisentan Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Ambrisentan Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • 5 mg Tablet
  • 10 mg Tablet
Applications
  • Hospital
  • Drug store
Companies covered
  • Gilead Sciences
  • Hansoh Pharma
  • GSK

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Ambrisentan Drug Market by Type
  3. 1.2.1 Global Ambrisentan Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 5 mg Tablet
  5. 1.2.3 10 mg Tablet
  6. 1.3 Ambrisentan Drug Market by Application
  7. 1.3.1 Global Ambrisentan Drug Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Drug store
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Ambrisentan Drug Market Dynamics
  1. 2.1 Ambrisentan Drug Industry Trends
  2. 2.2 Ambrisentan Drug Industry Drivers
  3. 2.3 Ambrisentan Drug Industry Opportunities and Challenges
  4. 2.4 Ambrisentan Drug Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Ambrisentan Drug Market Perspective (2021-2032)
  2. 3.2 Global Ambrisentan Drug Growth Trends by Region
  3. 3.2.1 Global Ambrisentan Drug Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Ambrisentan Drug Market Size by Region (2021-2026)
  5. 3.2.3 Global Ambrisentan Drug Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Ambrisentan Drug Revenue by Players
  2. 4.1.1 Global Ambrisentan Drug Revenue by Players (2021-2026)
  3. 4.1.2 Global Ambrisentan Drug Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Ambrisentan Drug Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Ambrisentan Drug Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Ambrisentan Drug Key Players Headquarters & Area Served
  7. 4.4 Global Ambrisentan Drug Players, Product Type & Application
  8. 4.5 Global Ambrisentan Drug Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Ambrisentan Drug Market CR5 and HHI
  11. 4.6.3 2025 Ambrisentan Drug Tier 1, Tier 2, and Tier 3
5 Ambrisentan Drug Market Size by Type
  1. 5.1 Global Ambrisentan Drug Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Ambrisentan Drug Revenue by Type (2021-2032)
  3. 5.3 Global Ambrisentan Drug Revenue Market Share by Type (2021-2032)
6 Ambrisentan Drug Market Size by Application
  1. 6.1 Global Ambrisentan Drug Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Ambrisentan Drug Revenue by Application (2021-2032)
  3. 6.3 Global Ambrisentan Drug Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Gilead Sciences
  2. 7.1.1 Gilead Sciences Company Information
  3. 7.1.2 Gilead Sciences Business Overview
  4. 7.1.3 Gilead Sciences Ambrisentan Drug Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Gilead Sciences Ambrisentan Drug Product Portfolio
  6. 7.1.5 Gilead Sciences Recent Developments
  7. 7.2 Hansoh Pharma
  8. 7.2.1 Hansoh Pharma Company Information
  9. 7.2.2 Hansoh Pharma Business Overview
  10. 7.2.3 Hansoh Pharma Ambrisentan Drug Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Hansoh Pharma Ambrisentan Drug Product Portfolio
  12. 7.2.5 Hansoh Pharma Recent Developments
  13. 7.3 GSK
  14. 7.3.1 GSK Company Information
  15. 7.3.2 GSK Business Overview
  16. 7.3.3 GSK Ambrisentan Drug Revenue and Gross Margin (2021-2026)
  17. 7.3.4 GSK Ambrisentan Drug Product Portfolio
  18. 7.3.5 GSK Recent Developments
8 North America
  1. 8.1 North America Ambrisentan Drug Revenue (2021-2032)
  2. 8.2 North America Ambrisentan Drug Revenue by Type (2021-2032)
  3. 8.2.1 North America Ambrisentan Drug Revenue by Type (2021-2026)
  4. 8.2.2 North America Ambrisentan Drug Revenue by Type (2027-2032)
  5. 8.3 North America Ambrisentan Drug Revenue Share by Type (2021-2032)
  6. 8.4 North America Ambrisentan Drug Revenue by Application (2021-2032)
  7. 8.4.1 North America Ambrisentan Drug Revenue by Application (2021-2026)
  8. 8.4.2 North America Ambrisentan Drug Revenue by Application (2027-2032)
  9. 8.5 North America Ambrisentan Drug Revenue Share by Application (2021-2032)
  10. 8.6 North America Ambrisentan Drug Revenue by Country
  11. 8.6.1 North America Ambrisentan Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Ambrisentan Drug Revenue by Country (2021-2026)
  13. 8.6.3 North America Ambrisentan Drug Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Ambrisentan Drug Revenue (2021-2032)
  2. 9.2 Europe Ambrisentan Drug Revenue by Type (2021-2032)
  3. 9.2.1 Europe Ambrisentan Drug Revenue by Type (2021-2026)
  4. 9.2.2 Europe Ambrisentan Drug Revenue by Type (2027-2032)
  5. 9.3 Europe Ambrisentan Drug Revenue Share by Type (2021-2032)
  6. 9.4 Europe Ambrisentan Drug Revenue by Application (2021-2032)
  7. 9.4.1 Europe Ambrisentan Drug Revenue by Application (2021-2026)
  8. 9.4.2 Europe Ambrisentan Drug Revenue by Application (2027-2032)
  9. 9.5 Europe Ambrisentan Drug Revenue Share by Application (2021-2032)
  10. 9.6 Europe Ambrisentan Drug Revenue by Country
  11. 9.6.1 Europe Ambrisentan Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Ambrisentan Drug Revenue by Country (2021-2026)
  13. 9.6.3 Europe Ambrisentan Drug Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Ambrisentan Drug Revenue (2021-2032)
  2. 10.2 China Ambrisentan Drug Revenue by Type (2021-2032)
  3. 10.2.1 China Ambrisentan Drug Revenue by Type (2021-2026)
  4. 10.2.2 China Ambrisentan Drug Revenue by Type (2027-2032)
  5. 10.3 China Ambrisentan Drug Revenue Share by Type (2021-2032)
  6. 10.4 China Ambrisentan Drug Revenue by Application (2021-2032)
  7. 10.4.1 China Ambrisentan Drug Revenue by Application (2021-2026)
  8. 10.4.2 China Ambrisentan Drug Revenue by Application (2027-2032)
  9. 10.5 China Ambrisentan Drug Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Ambrisentan Drug Revenue (2021-2032)
  2. 11.2 Asia Ambrisentan Drug Revenue by Type (2021-2032)
  3. 11.2.1 Asia Ambrisentan Drug Revenue by Type (2021-2026)
  4. 11.2.2 Asia Ambrisentan Drug Revenue by Type (2027-2032)
  5. 11.3 Asia Ambrisentan Drug Revenue Share by Type (2021-2032)
  6. 11.4 Asia Ambrisentan Drug Revenue by Application (2021-2032)
  7. 11.4.1 Asia Ambrisentan Drug Revenue by Application (2021-2026)
  8. 11.4.2 Asia Ambrisentan Drug Revenue by Application (2027-2032)
  9. 11.5 Asia Ambrisentan Drug Revenue Share by Application (2021-2032)
  10. 11.6 Asia Ambrisentan Drug Revenue by Country
  11. 11.6.1 Asia Ambrisentan Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Ambrisentan Drug Revenue by Country (2021-2026)
  13. 11.6.3 Asia Ambrisentan Drug Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Ambrisentan Drug Revenue (2021-2032)
  2. 12.2 SAMEA Ambrisentan Drug Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Ambrisentan Drug Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Ambrisentan Drug Revenue by Type (2027-2032)
  5. 12.3 SAMEA Ambrisentan Drug Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Ambrisentan Drug Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Ambrisentan Drug Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Ambrisentan Drug Revenue by Application (2027-2032)
  9. 12.5 SAMEA Ambrisentan Drug Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Ambrisentan Drug Revenue by Country
  11. 12.6.1 SAMEA Ambrisentan Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Ambrisentan Drug Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Ambrisentan Drug Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst